Invus Global Management, LLC - 16 Oct 2025 SCHEDULE 13G Report for Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value (RANI)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value
Symbol
RANI
Shares outstanding
98,357,467 shares
Disclosed Ownership
9,825,911 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
23 Oct 2025, 17:05:17 UTC
Date of event
16 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 10% ownership in Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value (RANI) on 16 Oct 2025."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value (RANI).
  • Disclosed ownership: 10%.
  • Date of event: 16 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Oct 2025, 17:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 10% 9,825,911 9,825,911 0 /s/ Raymond Debbane Raymond Debbane

Sponsored